MedPath

Optimal timing of solid food introduction to infants at high risk of developing allergic disease.

Not Applicable
Conditions
Eczema
Inflammatory and Immune System - Allergies
Skin - Dermatological conditions
Egg allergy
Registration Number
ACTRN12609000415202
Lead Sponsor
Women's and Children's Health Research Insitute
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Stopped early
Sex
All
Target Recruitment
226
Inclusion Criteria

Term singleton infants
Infants with symptoms of moderate to severe eczema
Both breastfed and formula fed infants

Exclusion Criteria

Infants who have commenced any solids prior to 4 months of age
Infants who have commenced egg containing solids prior to study entry
Infants who have any congenital or acquired disease or developmental disorder likely to affect infant feeding

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Immunoglobulin E (IgE) mediated egg allergy defined as an allergic reaction to a raw egg challenge and associated evidence of sensitisation to egg assessed by skin prick testing where a positive skin prick test has a mean weal diameter >3mm to egg. An allergic reaction will be defined as at least 3 concurrent non-contact urticaria persisting for at least 5 minutes and/or generalised skin erthema and/or vomiting and/or anaphylaxis (evidence of circulatory or respiratory involvement) within 2 hours of ingestion of raw egg[At 12 months of age]
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath